Charles G, Lundin A P, Delano B G, Brown C, Friedman E A
Int J Artif Organs. 1981 Nov;4(6):277-9.
Anemia is usual in untreated uremia. Persistent anemia is thought to be universal in uremic patients treated by maintenance hemodialysis (MH). A retrospective chart analysis of 549 patients on (MH) at five facilities in Brooklyn, found that eleven (2%) of these patients had a hematocrit (Hct) in the normal range (40%). To distinguish this subset of patients from the majority of MH, we compared both groups for: (1) etiology of the renal disease, (2) presence of residual renal function, (3) dialysis prescription, (4) decreased arterial O2 saturation, (5) greater use of vitamins or anabolic steroids, (6) absence of parathyroid disease. The relatively high hematocrit was not explained by any factor evaluated in this small subset of MH patients.
未治疗的尿毒症患者通常会出现贫血。持续性贫血被认为在接受维持性血液透析(MH)治疗的尿毒症患者中普遍存在。对布鲁克林五家机构的549例接受MH治疗的患者进行的回顾性病历分析发现,这些患者中有11例(2%)的血细胞比容(Hct)在正常范围内(40%)。为了将这一患者亚组与大多数接受MH治疗的患者区分开来,我们对两组患者进行了以下比较:(1)肾病病因,(2)残余肾功能的存在情况,(3)透析处方,(4)动脉血氧饱和度降低情况,(5)维生素或合成代谢类固醇的使用频率较高情况,(6)甲状旁腺疾病的不存在情况。在这一小部分接受MH治疗的患者中,相对较高的血细胞比容无法用所评估的任何因素来解释。